奥来德(688378) - 2025 Q3 - 季度财报
2025-10-30 13:50
Financial Performance - The company's operating revenue for the third quarter was ¥108,054,763.57, a decrease of 11.21% compared to the same period last year[3] - The total profit for the quarter was -¥1,464,994.92, reflecting a decline of 126.64% year-on-year[3] - The net profit attributable to shareholders was ¥4,351,201.56, down 53.90% from the previous year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥10,375,936.43, a decrease of 512.09% compared to the same period last year[3] - The basic earnings per share for the quarter was ¥0.02, a decline of 60.00% year-on-year[4] - The net profit attributable to shareholders for the year-to-date period was ¥31,356,053.44, down 69.03% year-on-year[3] - Total operating revenue for the first three quarters of 2025 was CNY 389,005,051.84, a decrease of 16.1% compared to CNY 463,790,658.79 in the same period of 2024[24] - Net profit for the first three quarters of 2025 was CNY 31,356,053.44, a decline of 69.0% from CNY 101,251,083.26 in the same period of 2024[25] - The total comprehensive income attributable to the parent company for the first three quarters of 2025 is CNY 30,178,881.56, compared to CNY 98,811,723.01 in the same period of 2024, representing a significant decrease[26] - Basic and diluted earnings per share for the first three quarters of 2025 are both CNY 0.13, down from CNY 0.49 in 2024[26] Research and Development - Research and development expenses totaled ¥36,273,753.17, accounting for 33.57% of operating revenue, a decrease of 0.50 percentage points from the previous year[4] - Research and development expenses for the first three quarters of 2025 were CNY 91,657,560.97, slightly up from CNY 90,362,260.30 in 2024[24] - The PSPI materials are in the stage of large-scale production, demonstrating the company's technological maturity and product competitiveness[17] - The new generation GP materials have made progress in market expansion, achieving multiple small-batch stable supplies to leading domestic panel manufacturers since 2025[17] Assets and Liabilities - Total assets increased to ¥2,352,834,881.26, representing a growth of 7.99% compared to the end of the previous year[4] - The company's total liabilities increased to CNY 687,419,360.61 from CNY 441,010,028.90, reflecting a growth of 55.8%[22] - Total equity attributable to shareholders decreased to CNY 1,665,415,520.65 from CNY 1,737,652,258.31, a decline of 4.1%[22] - The deferred income tax liabilities decreased to CNY 29,662.98 from CNY 122,412.75, indicating a reduction of 75.8%[22] Cash Flow - The company's cash and cash equivalents decreased from RMB 320.5 million at the end of 2024 to RMB 227.4 million as of September 30, 2025[19] - Net cash flow from operating activities for the first three quarters of 2025 is CNY 84,930,622.81, a recovery from a negative CNY 27,120,171.10 in the same period of 2024[27] - Cash inflow from operating activities totaled CNY 475,903,784.60 in 2025, compared to CNY 445,369,870.15 in 2024, indicating a year-over-year increase of approximately 6.0%[27] - Cash outflow from operating activities decreased to CNY 390,973,161.79 in 2025 from CNY 472,490,041.25 in 2024, reflecting a reduction of about 17.3%[27] - Net cash flow from investing activities for the first three quarters of 2025 is negative CNY 136,285,692.78, an improvement from negative CNY 185,451,768.81 in 2024[27] - Cash inflow from investing activities increased to CNY 594,001,436.04 in 2025, compared to CNY 268,213,979.96 in 2024, marking a substantial increase of approximately 121.5%[27] - Cash outflow from investing activities rose to CNY 730,287,128.82 in 2025 from CNY 453,665,748.77 in 2024, indicating an increase of about 60.9%[27] - Net cash flow from financing activities for the first three quarters of 2025 is negative CNY 49,047,807.86, an improvement from negative CNY 130,161,591.03 in 2024[27] - The ending cash and cash equivalents balance for the first three quarters of 2025 is CNY 203,081,624.07, compared to CNY 107,967,239.38 in 2024, showing an increase of approximately 88.2%[27] Shareholder Information - The company has a total of 8,114 common stock shareholders at the end of the reporting period[14] - The top 10 shareholders hold a combined 48.84% of the company's shares, with the largest shareholder owning 21.84%[14] Future Outlook - The company is transitioning its OLED panel production line from 6th generation to 8.6 generation, which has led to a temporary decline in equipment business demand[17] - The company’s cash flow from operating activities showed a significant change, with a focus on improving operational efficiency moving forward[25] - Future outlook includes potential market expansion and new product development strategies to enhance revenue streams[25]
中岩大地(003001) - 2025 Q3 - 季度财报
2025-10-30 13:40
北京中岩大地科技股份有限公司 2025 年第三季度报告 证券代码:003001 证券简称:中岩大地 公告编号:2025-094 北京中岩大地科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 ☑否 1 北京中岩大地科技股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 ☑否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末比上 年初至报告期末 | | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入(元) | 86,126,068.03 | -41.88 ...
新城控股(601155) - 2025 Q3 - 季度财报
2025-10-30 13:40
新城控股集团股份有限公司 2025 年第三季度报告 证券代码:601155 证券简称:新城控股 新城控股集团股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误 导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 √适用 □不适用 单位:元 币种:人民币 单位:元 币种:人民币 | 项目 | 本报告期 | 本报告期比上 | 年初至报告期 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 年同期增减变 | 末 | 比上年同期增减 | | | | 动幅度(%) | | 变动幅度(%) | | 营业收入 | 12,270,873,365 | -30.51 | ...
豪能股份(603809) - 2025 Q3 - 季度财报
2025-10-30 13:40
成都豪能科技股份有限公司 2025 年第三季度报告 证券代码:603809 证券简称:豪能股份 成都豪能科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 单位:元 币种:人民币 | | | 本报告期比上 | | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 年同期增减变 | 年初至报告期末 | | | | | 动幅度(%) | | 增减变动幅度 | | | | | | (%) | | 营业收入 | 641,751,890.11 | 16.25 | 1, ...
森特股份(603098) - 2025 Q3 - 季度财报
2025-10-30 13:35
森特士兴集团股份有限公司 2025 年第三季度报告 证券代码:603098 证券简称:森特股份 森特士兴集团股份有限公司 2025 年第三季度报告 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 624,882,285.57 | -1.38 | 2,244,345,295.26 | 19.05 | | | 27,931,227.72 | 32.77 | 111,599,152.01 | 30.89 | | | 24,221,904.97 | 46.28 | 96,277,463.91 | 30.16 | | 扣除非经常性损益的净 | 16,107,058.57 | 40.27 | 75,681,804.30 | 31.95 | | 项目 利润总额 归属于上市公司股东的 净利润 归属于上市公司股东的 利润 | | | | | 1 / 12 本公司董事会及全体董事保证 ...
锦龙股份(000712) - 2025 Q3 - 季度财报
2025-10-30 13:35
Financial Performance - Total operating revenue for Q3 2025 reached ¥225,821,486.39, an increase of 71.02% year-on-year[5] - Net profit attributable to shareholders was ¥27,323,903.61, representing a significant increase of 160.89% compared to the same period last year[5] - Basic earnings per share rose to ¥0.030, up 160.00% year-on-year, while diluted earnings per share also increased by the same percentage[5] - Total revenue for the first nine months of 2025 reached ¥643.07 million, a 31.07% increase compared to ¥490.65 million in the same period of 2024, primarily driven by investment income and increased commission fees[9] - Net commission income rose by 35.02% to ¥264.96 million from ¥196.23 million, attributed to increased trading activity in the securities market[9] - Investment income surged by 101.34% to ¥725.21 million, up from ¥360.19 million, mainly due to the sale of part of the equity in Dongguan Securities[9] - The net profit attributable to shareholders increased by 258.58% to ¥152.17 million, compared to a loss of ¥95.96 million in the previous year, driven by increased investment income from the sale of Dongguan Securities[9] - Net profit for the current period was ¥149,545,184.27, a significant recovery from a net loss of ¥42,043,492.33 in the previous period[16] - The total comprehensive income attributable to the parent company was approximately ¥136.19 million, compared to a loss of ¥79.15 million in the previous period[17] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥22,929,480,987.90, a decrease of 3.14% from the end of the previous year[5] - The company’s long-term equity investments decreased by 47.51% to ¥2,045,231,854.20, mainly due to the sale of part of its equity in Dongguan Securities[8] - The total liabilities decreased significantly, with borrowed funds down by 41.70% to ¥703,916,452.73[8] - The company’s financial liabilities totaled ¥18,370,357,866.67, down from ¥19,195,782,436.08, indicating a reduction of approximately 4.3%[15] - The company’s total liabilities to equity ratio stands at approximately 4.03, indicating a high leverage position[15] Cash Flow - Cash flow from operating activities for the year-to-date period was ¥847,470,576.19, down 54.38% compared to the previous year[5] - Cash inflow from operating activities decreased by 73.92% to ¥1.39 billion, down from ¥5.31 billion, primarily due to reduced cash inflows from repurchase and borrowing activities[9] - Cash inflow from investment activities skyrocketed by 1858.79% to ¥2.36 billion, compared to ¥120.57 million, mainly from the proceeds of selling Dongguan Securities[9] - Total cash outflow from financing activities decreased by 31.64% to ¥2.48 billion from ¥3.63 billion[9] - The net cash flow from operating activities was ¥847.47 million, down from ¥1.86 billion in the previous period[19] - The total cash inflow from investment activities was ¥2.36 billion, significantly higher than ¥120.57 million in the previous period[20] - The net cash flow from financing activities was -¥2.17 billion, compared to -¥543.84 million in the previous period[20] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 79,518, with the top ten shareholders holding significant stakes[11] - The company completed the transfer of 30 million shares of Dongguan Securities, constituting 20% of its total share capital, for a total consideration of ¥227,175.42 million[12] - The company plans to divest its 67.78% stake in Zhongshan Securities, which is classified as a major asset restructuring under regulations[13] Other Financial Metrics - The weighted average return on equity increased by 2.95 percentage points to 1.09% for the current period[5] - The company reported a significant increase in credit impairment losses of 241.52%, amounting to ¥1.66 million, compared to a reversal of ¥1.17 million in the previous year[9] - The fair value change in financial assets resulted in a loss of ¥140.26 million, a decline of 169.39% from a gain of ¥202.14 million in the previous year[9] - The company’s cash and cash equivalents increased to ¥7,342,528,368.03 from ¥6,215,431,673.56, marking a rise of about 18.1%[14] - The net interest income improved to -¥227,633,970.86 from -¥289,316,951.20, showing a positive trend in financial performance[16] - The company received cash from interest, fees, and commissions totaling ¥725.99 million, up from ¥581.70 million in the previous period[19] - The company reported a decrease in cash outflows for operating activities, totaling ¥537.56 million, compared to ¥3.45 billion in the previous period[19] - The company did not execute any mergers or acquisitions during the reporting period[17]
卓然股份(688121) - 2025 Q3 - 季度财报
2025-10-30 13:35
Financial Performance - The company's operating revenue for the third quarter was ¥599,018,433.89, representing a year-on-year increase of 5.39%[4] - The total profit for the period was ¥181,101,638.87, with a significant increase of 400.18% compared to the previous year[4] - The net profit attributable to shareholders was ¥59,774,164.25, showing a year-on-year increase of 74.55%[4] - The total profit for the current reporting period increased significantly due to the sale of equity in Zhuohe, resulting in a substantial asset disposal gain[9] - The net profit attributable to shareholders for the current period increased by 74.55% compared to the same period last year, primarily due to the asset disposal gain from the sale of Zhuohe's equity[9] - Net profit for the first three quarters of 2025 reached ¥162,988,802.62, a significant increase from ¥35,967,967.27 in the same period of 2024, representing a growth of approximately 353%[20] - Operating profit for the first three quarters of 2025 was ¥196,804,312.45, compared to ¥38,533,615.24 in 2024, indicating an increase of about 411%[20] - Total profit for the first three quarters of 2025 amounted to ¥190,190,136.03, up from ¥38,024,380.90 in 2024, reflecting an increase of approximately 400%[20] Cash Flow - The net cash flow from operating activities was -¥45,769,647.81, reflecting a decrease of 215.01% compared to the same period last year[4] - The net cash flow from operating activities decreased by 215.01% for the year-to-date period, attributed to reduced sales receipts and increased procurement payments[9] - Cash flow from operating activities for the first three quarters of 2025 was negative at -¥305,202,437.47, a decline from a positive cash flow of ¥265,379,883.70 in 2024[22] - The company generated cash inflows from operating activities totaling ¥1,207,431,239.19 in 2025, down from ¥1,660,391,693.42 in 2024[22] - Cash outflows from investing activities in the first three quarters of 2025 were ¥253,458,494.15, a decrease from ¥549,524,485.15 in 2024[23] Research and Development - Research and development expenses totaled ¥13,007,626.14, a decrease of 60.11% year-on-year, representing 2.17% of operating revenue[5] - Research and development expenses decreased by 60.11% for the current period, primarily due to a reduction in direct material usage compared to the same period last year[9] - Research and development expenses decreased to CNY 39,320,279.29 in 2025 from CNY 79,542,169.09 in 2024, representing a reduction of 50.6%[19] Assets and Liabilities - The total assets at the end of the period were ¥8,534,470,130.37, a decrease of 2.01% from the end of the previous year[5] - Total assets as of September 30, 2025, amounted to CNY 8,534,470,130.37, a slight decrease from CNY 8,709,093,988.78 at the end of 2024[17] - Total liabilities decreased to CNY 5,707,782,088.34 in 2025 from CNY 6,045,197,696.19 in 2024, reflecting a reduction of 5.6%[16] - Current assets totaled CNY 4,671,786,551.56 as of September 30, 2025, compared to CNY 4,659,356,647.46 at the end of 2024, showing a marginal increase[16] - Long-term equity investments increased to CNY 96,254,813.46 in 2025 from CNY 67,666,651.21 in 2024, indicating a growth of 42.3%[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 6,701[11] - The largest shareholder, Zhang Jinhong, holds 75,473,668 shares, representing 32.31% of the total shares[11] Earnings Per Share - The basic and diluted earnings per share were both -¥0.14, reflecting a decrease of 187.50% year-on-year[5] - Basic earnings per share for the first three quarters of 2025 were -¥0.14, compared to ¥0.16 in the same period of 2024[21] Comprehensive Income - The company reported a total comprehensive income of ¥163,051,995.29 for the first three quarters of 2025, compared to ¥35,988,785.06 in 2024, marking an increase of approximately 353%[20] Financing Activities - The company raised ¥1,727,696,177.74 through financing activities in the first three quarters of 2025, compared to ¥886,770,747.41 in 2024, indicating an increase of approximately 95%[23]
翔宇医疗(688626) - 2025 Q3 - 季度财报
2025-10-30 13:35
Financial Performance - The company's operating revenue for the third quarter was ¥177,983,291.97, an increase of 5.46% compared to the same period last year[4]. - The total profit for the quarter decreased by 71.05% to ¥5,236,453.20, while the net profit attributable to shareholders fell by 48.82% to ¥8,586,869.79[4][8]. - The basic earnings per share for the quarter was ¥0.06, down 45.45% from the same period last year[4][8]. - The company's total profit for the year-to-date period decreased by 44.06% to ¥44,305,425.87[4][8]. - Net profit for the first three quarters of 2025 was ¥41,907,442.75, a decrease of 43% from ¥73,382,295.90 in the previous year[22]. - Basic earnings per share for the period was ¥0.29, down from ¥0.47 in the same period last year[23]. Research and Development - Research and development expenses amounted to ¥49,094,672.85, representing 27.58% of operating revenue, an increase of 4.80 percentage points year-on-year[5]. - Research and development expenses rose to ¥125,479,123.87, an increase of 20.5% compared to ¥104,122,259.04 in 2024[21]. - The company achieved a total of 387 medical device registration certificates and filings, with 10 new additions during the reporting period[12]. - The company obtained 87 new patents, including 30 invention patents, bringing the total to 1,936 patents[12]. - The company has accumulated 2,340 intellectual property rights, including 1,070 utility model patents[14]. Assets and Liabilities - The total assets of the company increased by 11.76% to ¥3,272,197,143.87 compared to the end of the previous year[5]. - Total assets increased to ¥3,272,197,143.87, compared to ¥2,927,874,338.81 at the end of the previous year[19]. - Total liabilities rose to ¥1,231,446,217.25, up from ¥873,096,802.37 year-over-year[19]. - The company's equity attributable to shareholders decreased to ¥2,026,726,626.27 from ¥2,038,679,134.12 in the previous year[19]. Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥71,197,504.58, a decrease of 23.43% compared to the previous year[4]. - Cash inflow from operating activities for the first three quarters of 2025 was $693.38 million, an increase of 8.8% compared to $637.26 million in the same period of 2024[25]. - Net cash flow from operating activities decreased to $71.20 million in 2025 from $92.98 million in 2024, reflecting a decline of 23.5%[25]. - Total cash inflow from investment activities was $106.16 million in 2025, significantly lower than $324.26 million in 2024, marking a decrease of 67.2%[26]. - Net cash flow from investment activities was -$295.11 million in 2025, worsening from -$186.98 million in 2024[26]. - Cash inflow from financing activities increased to $818.50 million in 2025, compared to $492.00 million in 2024, representing a growth of 66.3%[26]. - Net cash flow from financing activities was $255.14 million in 2025, up from $151.23 million in 2024, indicating a rise of 68.7%[26]. - The ending cash and cash equivalents balance for 2025 was $734.13 million, compared to $709.13 million in 2024, showing an increase of 3.5%[26]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 9,531[10]. - The largest shareholder, Henan Xiangyu Health Industry Management Co., Ltd., holds 56.43% of the shares[10]. - The company has a total of 90,286,560 shares held by Henan Xiangyu Health Industry Management Co., Ltd., representing a significant shareholder[11]. Achievements and Recognition - The company successfully led a major scientific project in Henan Province focused on key technologies for traditional Chinese medicine therapy robots[12]. - The company was awarded the third prize in military scientific and technological progress[13]. - The company has been recognized as a member of the Brain-Computer Interface Technology Innovation and Industry Service Alliance[13]. - The company’s intelligent workshop for rehabilitation medical devices was rated as a smart workshop in Henan Province for 2025[13].
空港股份(600463) - 2025 Q3 - 季度财报
2025-10-30 13:30
证券代码:600463 证券简称:空港股份 北京空港科技园区股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是√否 北京空港科技园区股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 单位:万元 币种:人民币 | 项目 | 本报告期 | 上年同期 | | 本报告期 比上年同 期增减变 | 年初至报 | | | 年初至报 告期末比 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | 上年同期 | | 上年同期 | | | | | | 动幅度(%) | 告期末 | ...
隧道股份(600820) - 2025 Q3 - 季度财报
2025-10-30 13:30
Financial Performance - The company's operating revenue for Q3 2025 was approximately ¥12.37 billion, a decrease of 16.73% compared to ¥14.85 billion in the same period last year[3]. - Total profit for the quarter was approximately ¥622.06 million, down 29.64% from ¥881.99 million year-over-year[3]. - Net profit attributable to shareholders was approximately ¥482.81 million, representing a decline of 32.47% from ¥713.81 million in the previous year[3]. - Basic earnings per share for the quarter were ¥0.14, down 39.13% from ¥0.23 in the same quarter last year[4]. - The weighted average return on equity was 1.68%, a decrease of 0.72 percentage points compared to the previous year[4]. - Net profit for the first three quarters of 2025 was ¥1.23 billion, a decline of 23.8% from ¥1.62 billion in the same period of 2024[20]. - The basic earnings per share for the first three quarters of 2025 was ¥0.35, down from ¥0.48 in the same period of 2024[20]. Cash Flow - The net cash flow from operating activities decreased by 85.03%, dropping to approximately ¥357.49 million from ¥2.39 billion year-to-date[3][10]. - In the first three quarters of 2025, the cash inflow from operating activities was CNY 41.94 billion, a decrease of 7.3% compared to CNY 46.30 billion in the same period of 2024[21]. - The net cash flow from operating activities was CNY 357.49 million, significantly down from CNY 2.39 billion in the previous year, reflecting a decline of 85.0%[21]. - Total cash inflow from investment activities was CNY 2.58 billion, an increase of 31.5% from CNY 1.96 billion in the same period of 2024[22]. - The net cash flow from investment activities was CNY 353.51 million, down 50.3% from CNY 711.61 million in the previous year[22]. - Cash inflow from financing activities totaled CNY 27.30 billion, up 45.3% from CNY 18.81 billion in the same period of 2024[22]. - The net cash flow from financing activities was negative at CNY 3.59 billion, an improvement from a negative CNY 4.67 billion in the previous year[22]. - The ending balance of cash and cash equivalents was CNY 20.55 billion, an increase from CNY 19.47 billion at the end of the same period in 2024[22]. - The company received CNY 3.98 billion from investment absorption, which is a 91.0% increase compared to CNY 2.09 billion in the previous year[22]. - The company paid CNY 18.00 million to minority shareholders, compared to CNY 59.73 million in the previous year[22]. - The company reported a decrease in cash received from sales of goods and services, totaling CNY 40.81 billion, down 2.5% from CNY 45.09 billion in the same period of 2024[21]. Assets and Liabilities - Total assets at the end of the reporting period were approximately ¥171.90 billion, a slight decrease of 0.49% from ¥172.74 billion at the end of the previous year[4]. - Total current assets amount to ¥97,329,150,594.54, a slight decrease from ¥98,540,407,523.87 in the previous period[14]. - Total liabilities include short-term borrowings of ¥10,038,305,012.31, an increase from ¥5,530,762,517.99[14]. - The company's total liabilities decreased to ¥129.99 billion in 2025 from ¥133.35 billion in 2024, reflecting a reduction of 2.7%[16]. - The total equity attributable to shareholders increased to ¥39.12 billion in 2025 from ¥34.64 billion in 2024, representing a growth of 12.8%[16]. - The deferred income tax liabilities decreased to ¥838.55 million in 2025 from ¥1.00 billion in 2024, a reduction of 16.2%[15]. - The company has a long-term equity investment valued at ¥6,106,308,180.72, down from ¥6,694,365,066.19[14]. - The company reported inventory of ¥1,475,199,468.59, an increase from ¥1,158,876,991.15[14]. - The company has a goodwill of ¥64,702,412.91, unchanged from the previous period[14]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 122,562[12]. - The largest shareholder, Shanghai Tunnel Engineering Group Co., Ltd., holds 1,021,598,422 shares, accounting for 32.49% of total shares[12]. Future Outlook - The company plans to focus on improving operational efficiency and exploring new market opportunities to enhance future performance[10].